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A B S T R A C T
Objective: To determine the cardiotocograph (CTG) changes in women with symptomatic COVID-19
infection.
Study design: 12 anonymised CTG traces from 2 hospitals in Spain were retrospectively analysed by 2
independent assessors. CTG parameters were studied based on fetal pathophysiological responses to
inflammation and hypoxia that would be expected based on the pathogenesis of COVID-19 patients.
Correlation was made with perinatal outcomes (Apgar score at 5 min and umbilical cord pH).
Results: All fetuses showed an increased baseline FHR > 10 percent compared to the initial recording, in
addition to absence of accelerations. 10 out of 12 CTG traces (83.3 percent) demonstrated late or
prolonged decelerations and 7 out of 12 fetuses (58.3 percent) showed absence of cycling. Not a single
case of sinusoidal pattern was observed. ZigZag pattern was found in 4 CTG traces (33 percent). Excessive
uterine activity was observed in all CTG traces where uterine activity was monitored (10 out of 12). Apgar
scores at 5 min were normal (>7) and absence of metabolic acidosis was found in the umbilical cord
arterial pH (pH > 7.0) in the cases that were available (11 and 9, respectively).
Conclusion: Fetuses of COVID-19 patients showed a raised baseline FHR (>10 percent), loss of
accelerations, late decelerations, ZigZag pattern and absence of cycling probably due to the effects of
maternal pyrexia, maternal inflammatory response and the “cytokine storm”. However, the perinatal
outcomes appear to be favourable. Therefore, healthcare providers should optimise the maternal
environment first to rectify the reactive CTG changes instead of performing an urgent operative
intervention.
© 2020 Elsevier B.V. All rights reserved.
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The parameters recorded on the cardiotocograph (CTG) reflect
the activity of fetal autonomic and somatic nervous systems, as
well as the oxygenation of the fetal myocardium [1]. A fetus
responds to hypoxia by reducing the myocardial workload to
maintain a positive aerobic metabolism in the heart, seen as
decelerations on the CTG trace [1]. Excessive uterine irritability




0301-2115/© 2020 Elsevier B.V. All rights reserved.myometrial blood vessels, as well as causing compression of the
umbilical cord [2].
CTG changes are also influenced by maternal status. Hypoxic
and inflammatory conditions, as well as maternal pyrexia, can
cause abnormal fetal heart rate changes. Maternal fever increases
her oxygen requirement (thereby reducing utero-placental oxygen
transfer), as well as increases placental oxygen consumption given
the augmented metabolism of the feto-placental unit. This can
result in fetal hypoxic neurological injury.
COVID-19 infection is associated with maternal pyrexia,
“cytokine storm” and hypercoagulability, which increases the risk
of placental intervillous thrombosis and infarction, as well as
maternal hypoxia secondary to adult respiratory distress syn-
drome (ARDS).
Table 1
Analysis of CTG features in women with COVID-19 infection.
Case Gestational age Baseline FHR > 10 % Variability Cycling Accelerations Decelerations Sinusoidal Uterine irritability Apgar 5 Cord arterial pH
1 37 + N – – Late – + 10 7.3 (V)
Prolonged
2 39.5 + N + – Late – + 10 7.12
3 36.4 + N – – Late – Not Recorded 10 –
4 40.6 + Reduced – – Late – + 10 –
5 28 >200 – – – – – Not Recorded N/A N/A
6 40 + Reduced – – Late – + 10 7.14
7 37.3 + ZigZag + – Late – + 10 7.28
Prolonged
8 37.6 + N + – Variable – + 10 7.23
9 38.3 + ZigZag + – Late – + 10 7.28
10 40.6 + ZigZag + – Late – + 9 7.31
11 39.4 + Reduced – – Late – + 9 7.26
12 39 + ZigZag – – Late – + 9 7.23
FHR = fetal heart rate; N = normal; V = venous.
Table 2
Anticipated CTG features in COVID-19 patients.
CTG feature Normal parameters COVID-19
Likely changes in COVID-19 Underlying reason Correlation pathogenesis
Baseline FHR 110160 bpm After 40 weeks the upper
limit is 150 bpm (strong vagal
dominance)
Increased FHR > 10 % bpm or
>10 % above expected for
gestational age




Gross fetal tachycardia (FHR
> 180 bpm)
Fetal response to intense
maternal inflammation.
"Cytokine Storm"
Acute fetal bradycardia Placental intervillous
thrombosis or acute
maternal hypoxia.
Hypercoagulable state and ARDS
leading to maternal hypoxia and
reduction in placental circulation.
Baseline
variability





the effects of inflammatory
cytokines
COVID-19 is associated with ARDS and
"Cytokine Storm", releasing TNF-alfa,
interferons and interleukins that can
cross the placenta and the fetal blood-
brain barrier causing depression of fetal
CNS. Opiates and other CNS depressants
can also cause depressed variability.
Increased variability (> 25






Maternal pyrexia may increase fetal
core body temperature. The "Cytokine
Storm" may cause fetal autonomic
instability.
Cycling Alternate periods of normal and
reduced variability (approx. once in
every 50 min) due to active and quiet
fetal sleep
Loss of cycling with either
the absence of the quiet
epoch or persistent reduced
variability.
Depression of the fetal CNS
due to persistent maternal
pyrexia and / or
inflammatory mediators
that cross the placenta.
Maternal pyrexia and the "Cytokine
Storm"
Accelerations A transient rise in the FHR with the
amplitude of 15 bpm lasting for 15 s, at
least 2 episodes in 20 min.
Loss of accelerations Fetus conserve body
movements during hypoxia.
ARDS leading to maternal hypoxia and
the resultant reduction in placental
circulation.
Loss of fetal movements as a
result of CNS depression due
to inflammatory mediators.
COVID-19 is associated with maternal
"Cytokine Storm" and these toxic
cytokines may cross the placenta.
Increased accelerations Intrauterine fetal convulsion Maternal pyrexia may increase fetal
core body temperature leading to fetal
hyperpyrexia and febrile convulsion.
Deceleration Late or "shallow"
declarations with delayed






ARDS leading to maternal hypoxia and
reduction in placental circulation as
well as due to the hypercoagulable
state.
A transient decrease in the FHR of at
least 15 bpm from the normal baseline








Hypercoagulable state in COVID-19
patients may lead to placental
thrombosis and infarction.
Single prolonged
deceleration (>30 bpm drop,
for > 3 min) and an acute
fetal bradycardia (>30 bpm
drop for > 10 min).
Infarction and thrombosis of
>50 % of placenta, and/or
secondary to an acute
reduction in utero-placental
perfusion.
Hypercoagulability may lead to massive
placental thrombosis and infarction
ARDS leading to an acute maternal
hypoxia and/ or hypotension causing an
acute reduction in placental
oxygenation.
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Table 2 (Continued)
CTG feature Normal parameters COVID-19
Likely changes in COVID-19 Underlying reason Correlation pathogenesis
Sinusoidal
Pattern
Typical Smooth undulated oscillations of the
FHR baseline with amplitude of 15 bpm
and frequency 25/min, reduced
variability and absence of accelerations.
Due to fetal thumb-sucking and
physiological glottic movements that
occur for upto 30 min.
Persistence of typical
sinusoidal pattern for longer
than 30 min
Chronic fetal anaemia and
acidosis
Destruction of red cells have been
reported in patients with COVID-19.
This may not only reduce oxygen
carrying capacity of maternal blood to
the placenta, if a similar effect occurs in




Atypical Sharp, “Shark-teeth-like” oscillation of
the baseline FHR, persisting for up to 10
min secondary to fetal thumb sucking.






DIC has been reported in COVID-19
patients. If similar changes affect the
fetoplacental unit, this may result in an
acute feto-maternal haemorrhage and
fetal hypovolemia.
34 in 10 min, lasting <60 s with inter-
contraction interval of >90 s.





FHR = Fetal heart rate; ADRS = Adult Distress Syndrome; DIC = Disseminated Intravascular Coagulation; bpm = beats per minute.
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19 infection has a direct effect on fetal morbidity and mortality,
maternal changes secondary to COVID-19 infection may result in
fetal heart rate changes.Fig. 1. Absence of accelerations in the CTG trPathogenesis of the COVID-19 infection
Recent studies have suggested that hypoxia and adult
respiratory distress syndrome (ARDS) may cause the release of aace of a patient with COVID-19 infection.
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trolled systemic inflammatory response resulting from the release
of large amounts of pro-inflammatory cytokines (IFN-a, IFN-g, IL-
1b, IL-6, IL-12, IL-18, IL-33, TNF-a, TGFb, etc.) and chemokines
(CCL2, CCL3, CCL5, CXCL8, CXCL9, CXCL10) have also been reported
[3]. Moreover, it has been suggested that recruitment of aberrant
CD45RA + T cells is the immunologic feature of COVID-19 [4].
Furthermore, it has been postulated that SARS-CoV-2 can
dissociate oxy-Hb, carboxy-Hb and glycosylated Hb. This may
result in prolonged and progressive hypoxia eventually leading to
desaturation and respiratory distress.
Excessive secretion of erythropoietin to stimulate the
bone marrow (in order to secrete new red blood cells to
compensate for progressive and profound hypoxia) may lead to
thrombocytosis and a resultant hypercoagulable state. Evidence of
disseminated intravascular coagulation (DIC) significantly higher
D-dimer (p < 0.05), fibrin degradation products (FDP) levels
(p < 0.05), and prolonged PT (p < 0.05) and APTT (p < 0.05) has
been documented [5]. A case with poor neonatal outcome with an
Apgar score of 0 and unsuccessful neonatal resuscitation [6] and
the adverse effect on the type 2 Pneumocytes have been recently
reported [7].
Therefore, COVID-19 results in an immunological response in a
pregnant woman whose immune system is already altered as a
result of normal physiological changes of pregnancy. Despite the
lack of strong evidence that COVID-19 is transferred in sufficient
load across the placenta to cause fetal infection or an inflammatoryFig. 2. Late decelerations in the CTG traceresponse [8–10], it is likely that there would be a reactive response
of the fetus secondary to a maternal inflammatory state. In
addition, maternal pyrexia, inflammatory mediators and cytokines
may irritate the uterine myometrium leading to a reduction in
utero-placental oxygen transfer.
Materials & methods
Retrospective analysis of 12 anonymised CTG traces from
pregnant women with symptomatic COVID-19 infection, from two
different hospitals in Spain, was performed. (Table 1). The CTG
traces were independently analysed by two assessors (AGPB and
EC) to determine the expected changes in maternal COVID-19
infection (Table 2) and correlated with perinatal outcomes (Apgar
Score at 5 min, and umbilical cord pH). Poor neonatal outcomes
were defined by 5 min Apgar Score < 7, umbilical cord arterial pH <
7.0 and unexpected admission to the neonatal unit.
Theory
Maternal inflammatory response and fever will affect the fetal
heart rate (FHR), thereby resulting in changes on the CTG trace.
Firstly, based on the fact that maternal interleukines and cytokines
have the ability to cross the placenta, it is reasonable to expect
reactive fetal tachycardia. The “cytokine storm” is likely to increase
the fetal heart rate >180 bpm due to its direct effect on the fetal
myocardium, in addition to an inflammatory response. Secondly, of a patient with COVID-19 infection.
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utero-placental insufficiency. This might be seen in the CTG trace
as chemo-receptor mediated “late decelerations”.
On the other hand, if inflammatory mediators affect the fetal
central nervous system, one would expect to see changes in fetal
variability, including the loss of cycling and the ZigZag pattern
secondary to autonomic instability [11].
Moreover, due to maternal hypercoagulable state, there may be
increased incidence of intrauterine fetal growth restriction (IUGR),
and sudden bradycardia secondary to placental or umbilical
venous thrombosis.
Lastly, in cases of severe maternal hypoxia or anaemia,
sinusoidal patterns may occur.
The anticipated CTG changes based on the pathogenesis of
COVID-19 infection are provided in Table 2.
Results
All fetuses showed an increased baseline FHR > 10 % compared to
the initial recording and one fetus (No. 5) showed gross fetalFig. 3. Prolonged deceleration in the CTG tratachycardia (>210 bpm). All fetuses showed absence of accelerations
(Fig.1). Late (Fig. 2) orprolonged decelerations (Fig. 3) were observed
in 10 out of 12 CTG traces (83.3 %) CTG traces. 7 out of 12 fetuses (58.3
%) showed absence of cycling (Fig. 4). Exaggerated or augmented
variability >25bpmwas found in 4 out of 12 cases (33 %) confirming a
ZigZag pattern (Fig. 5). None of the CTGs demonstrated a sinusoidal
pattern. All CTG traces (100 %) where uterine activity was monitored
(10 out of 12 cases) showed evidence of excessive uterine activity. In
the cases where delivery was accomplished (11 out of 12), the Apgar
scores at 5 min were normal (>7). Umbilical cord arterial pH was
available in9 cases,andnoneshowedevidence ofneonatal metabolic
acidosis (defined as pH < 7.0).
Discussion
To our best knowledge, this is the first study that analysed the
CTG changes in maternal COVID-19 infection using pathophysiol-
ogy according to the International Physiological CTG Guidelines
produced by 36 CTG experts from 14 countries in 2018 (https://
physiological-ctg.com/guideline.html). As expected, all fetusesce of a patient with COVID-19 infection.
Fig. 4. Absence of cycling in the CTG trace of a patient with COVID-19 infection.
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recording, which was suggestive of reactive fetal response to
maternal pyrexia and inflammatory response. The gross fetal
tachycardia (>210 bpm) seen in one case was most likely secondary
to the maternal “cytokine storm” resulting in excessive fetal
sympathetic response and/or due to cardiac arrythmia secondary
to excessive inflammatory mediators. All fetuses showed absence
of accelerations (Fig. 1). This was most likely secondary to the
depression of the fetal somatic nervous system by inflammatory
mediators or due to ongoing hypoxia as a result of increased
maternal or placental oxygen consumption leading to conservation
of fetal somatic muscle activity. Late (Fig. 2) or prolonged
decelerations (Fig. 3) which were observed in 10 out of 12 CTG
traces (83.3 %), were either secondary to increased placental
metabolism and resultant reduced utero-placental oxygen transfer
(i.e. a relative utero-placental insufficiency), or due to placental
intervillous thrombosis secondary to maternal hypercoagulable
state in COVID-19 infection.
58.3 % showed absence of cycling (Fig. 4), which was most likely
due to the loss of the normal active and quiet sleep epochs
secondary to placental transfer of maternal inflammatory medi-
ators, and resultant depressive effect on the fetal brain. Exagger-
ated or augmented variability >25bpm found in 33 % confirming a
ZigZag pattern, was most likely secondary to an autonomic
instability as a result of fetal inflammatory response secondary to
maternal cytokine storm and pyrexia. None of the CTGsdemonstrated a sinusoidal pattern which was suggestive that a
chronic fetal anaemia secondary to haemolysis is a rare
phenomenon in maternal COVID-19 infection. All CTG traces
(100 %) where uterine activity was monitored (10 out of 12 cases)
showed evidence of excessive uterine activity, which was most
likely secondary to myometrial irritability due to maternal pyrexia
and inflammatory response. In the cases where delivery was
accomplished (11 out of 12), the Apgar scores at 5 min were normal
(>7). Umbilical cord arterial pH was available in 9 cases, and these
showed absence of evidence of neonatal metabolic acidosis (pH >
7.0). These indicate that despite the observed abnormal patterns
such as absence of accelerations, increased baseline FHR and the
presence of late or single prolonged decelerations on the CTG
traces, the perinatal outcomes were favourable. This suggest that
the observed abnormalities on the CTG trace were reactive changes
in the fetus secondary to the pathophysiology o the maternal
COVID-19 infection. This may have a significant clinical application
as performing an urgent operative delivery or adjunctive tests such
as fetal scalp blood sampling for a “pathological CTG trace” in
COVID-19 patients should be reviewed. Immediate measures to
improve the maternal environment to correct maternal hypoxia,
maternal pyrexia and inflammatory response should be undertak-
en to rectify CTG changes, prior to considering any intervention
based on the observed abnormal CTG changes. This is because the
primary causes of abnormal CTG changes in maternal COVID-19
infection are present within the maternal compartment. It is also
Fig. 5. ZigZag pattern (exaggerated variability) in the CTG trace of a patient with COVID-19 infection.
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maternal COVID-19 infections. By doing so unnecessary operative
interventions based on CTG guidelines -which are produced to
detect intrapartum hypoxia- could be avoided in maternal COVID-
19 infection, where the primary pathology is inflammation and not
hypoxia.
The main strength of our study is that the authors analysed the
CTG features that would be expected in maternal COVID-19
patients based on the knowledge of pathophysiology, instead of
relying on standard CTG guidelines (FIGO, NICE, ACOG or National)
which are intended to recognise intrapartum hypoxia and not
inflammation. COVID-19 infection is currently of immense clinical
significance and therefore, we hope the findings in our study will
help avoid unnecessary operative interventions for abnormal CTG
changes. This may help avoid additional metabolic and stress
response to an operative intervention in a woman who is already
symptomatic of COVID-19 infection.
The main limitation of our study is the small number. However,
symptomatic maternal COVID-19 infection is a novel, relatively
rare condition, and therefore, there is an urgent need to informfrontline clinicians of the abnormal CTG changes observed and the
associated perinatal outcomes. So that unnecessary operative
interventions are avoided in pregnant women with symptomatic
COVID-19 infection.
Conclusion
Maternal COVID-19 infection appears to cause changes in the
cardiotocograph (CTG) trace due to a combination of effects. These
include maternal hypoxia, “cytokine storm”, maternal pyrexia,
uterine irritability and diminished transfer of oxygen through the
placenta. This can be a consequence of increased placental
metabolic demands and / or placental intervillous thrombosis
secondary to maternal hypercoagulable state. However, as these
are due to the pathology in the maternal environment, despite the
abnormal features observed on the CTG trace, the neonatal
outcome appears to be favourable. Therefore, when abnormalities
are observed on the CTG trace, clinicians should aim to correct the
pathology related to COVID-19 within the mother, in order to
eliminate the detrimental effects of the maternal environment on
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rapidly transferring the mother for an operative delivery for a
“pathological CTG”. It is highly likely that by correcting the adverse
maternal environment, the CTG changes secondary to the effects of
COVID-19 infection could be reversed. It is hoped that future
research may help determine the time taken for the CTG changes to
resolve after the correction of adverse maternal environment.
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